ArticlePloS one2026
Maternal and cross-stage effects of Metarhizium pingshaense fungal infection on the malaria mosquito Anopheles coluzzii life-history.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEntomopathogenic fungi of the genus Metarhizium are widely used as eco-friendly biocontrol agents against insect vectors, offering a cost-effective alternative to chemical insecticides. While these fungi have demonstrated potential as larvicides against malaria vectors, their impacts on mosquito life-history traits and maternal effects remain poorly understood. This study evaluated the effects of locally isolated Metarhizium pingshaense strains (S10 and S26) on survival, development, reproductive fitness, and maternal effects in Anopheles coluzzii mosquitoes.
methodsWe assessed the efficacy of M. pingshaense (strains S10 and S26) against both larval and adult stages of An. coluzzii. For larval assays, third-instar larvae were reared in water containing 2 × 105 conidia/mL of M. pingshaense. Adult survival, wing length, oviposition rate, and blood-feeding behavior were subsequently measured. For adult assays, female mosquitoes were sprayed with spore suspensions of strains S10 and S26, and survival of their offspring was assessed. Survival data were analyzed using a Cox proportional hazards model, while other life-history traits were analyzed using generalized linear mixed models (GLMMs). All experiments were performed in triplicate to ensure reproducibility.
resultsExposure to fungal suspensions during the larval stage caused significant mortality at the pupal stage (~30%) compared to untreated controls. Adults emerging from treated larvae showed reduced survival (~23%) relative to controls, while wing length and blood-feeding behavior were unaffected. Adult female exposure to fungal spores increased egg-laying compared to controls, but a lower proportion of those larvae developed successfully into adults, demonstrating cross-stage and maternal effects.
conclusionThe results demonstrate the potential of M. pingshaense conidia as a biocontrol agent for An. coluzzii larvae, with additional cross-stage and maternal effects that further reduce mosquito fitness. These findings support the inclusion of M. pingshaense in integrated vector management strategies. Future work should focus on elucidating the molecular mechanisms underlying larval susceptibility and optimizing fungal formulations to enhance virulence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.